Stock listing
Stuttgart:1RV Rhythm Pharmaceuticals, Inc. Aktie
German listing (Stuttgart) of Rhythm Pharmaceuticals, Inc. · home listing NASDAQ:RYTM
Follow Rhythm Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:RYTM
$90.20 USD +1.97 (+2.2%)
Close on Oct 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:RYTM
- Day range
- $88.56 – $91.88 USDOct 20, 2026
- Volume
- 874,158 sharesOct 20, 2026
- Market cap
- $6.21B USDAt the close on Oct 20, 2026 · price × 68.85M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:RYTM · Home | $90.20 USD | +1.97 (+2.2%) | 874,158 | $88.56 | $91.88 | $88.56 | $88.23 | Close on Oct 20, 2026 |
| Frankfurt:1RV | €75.50 EUR | +1.50 (+2.0%) | — | €77.50 | €77.50 | €75.50 | €74.00 | Close on Oct 20, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 20, 2026 · NASDAQ:RYTM · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $90.20 | +1.97 | +2.2% | $88.56 | $91.88 | $88.56 | 874,158 | |
| $88.23 | +2.06 | +2.4% | $87.04 | $88.76 | $86.59 | 378,783 | |
| $86.17 | -1.80 | -2.0% | $88.20 | $88.62 | $85.91 | 364,054 | |
| $87.97 | +1.26 | +1.5% | $88.41 | $90.36 | $87.61 | 547,683 | |
| $86.71 | +0.10 | +0.1% | $86.41 | $88.14 | $85.38 | 583,655 | |
| $86.61 | -3.21 | -3.6% | $89.63 | $90.51 | $86.35 | 623,190 | |
| $89.82 | -0.96 | -1.1% | $91.05 | $91.42 | $89.49 | 543,800 | |
| $90.78 | +1.14 | +1.3% | $89.67 | $93.35 | $89.41 | 1,411,400 | |
| $89.64 | +1.19 | +1.3% | $89.05 | $90.94 | $87.01 | 1,008,500 | |
| $88.45 | -2.32 | -2.6% | $90.77 | $91.37 | $88.23 | 939,400 | |
| $90.77 | -1.68 | -1.8% | $92.55 | $94.47 | $90.07 | 992,900 | |
| $92.45 | -0.38 | -0.4% | $93.95 | $94.41 | $89.53 | 1,027,200 | |
| $92.83 | -0.58 | -0.6% | $94.97 | $95.32 | $92.66 | 503,500 | |
| $93.41 | -1.805 | -1.9% | $95.34 | $96.48 | $93.00 | 850,600 | |
| $95.22 | -0.495 | -0.5% | $96.67 | $97.37 | $95.10 | 737,200 | |
| $95.71 | -2.85 | -2.9% | $97.92 | $98.91 | $94.51 | 810,900 | |
| $98.56 | -0.10 | -0.1% | $98.01 | $99.15 | $95.27 | 897,400 | |
| $98.66 | +0.35 | +0.4% | $98.41 | $99.45 | $96.35 | 864,300 | |
| $98.31 | +0.07 | +0.1% | $97.73 | $99.28 | $95.38 | 730,800 | |
| $98.24 | -1.03 | -1.0% | $99.27 | $100.02 | $96.47 | 696,400 | |
| $99.27 | +0.44 | +0.4% | $100.44 | $101.85 | $98.69 | 499,900 | |
| $98.83 | +1.12 | +1.1% | $98.47 | $100.76 | $97.54 | 613,600 | |
| $97.71 | -1.31 | -1.3% | $99.36 | $99.36 | $96.88 | 1,124,800 | |
| $99.02 | +1.01 | +1.0% | $101.17 | $102.00 | $98.80 | 617,700 | |
| $98.01 | +1.24 | +1.3% | $97.69 | $100.85 | $97.06 | 921,400 | |
| $96.77 | -5.67 | -5.5% | $101.66 | $101.66 | $96.14 | 914,300 | |
| $102.44 | -2.27 | -2.2% | $105.27 | $105.93 | $101.09 | 789,700 | |
| $104.71 | +2.51 | +2.5% | $102.96 | $106.57 | $102.25 | 573,700 | |
| $102.20 | +1.14 | +1.1% | $99.88 | $102.89 | $99.88 | 422,900 | |
| $101.06 | -0.74 | -0.7% | $100.23 | $101.77 | $99.83 | 478,600 | |
| $101.80 | -0.94 | -0.9% | $100.58 | $103.31 | $99.41 | 513,000 | |
| $102.74 | -2.15 | -2.0% | $103.53 | $105.71 | $101.25 | 466,900 | |
| $104.89 | -0.53 | -0.5% | $106.08 | $106.08 | $103.90 | 269,800 | |
| $105.42 | +0.68 | +0.6% | $105.50 | $108.57 | $103.95 | 455,600 | |
| $104.74 | -1.39 | -1.3% | $105.79 | $108.43 | $104.09 | 332,000 | |
| $106.13 | -1.04 | -1.0% | $106.01 | $108.85 | $103.98 | 775,200 | |
| $107.17 | -5.36 | -4.8% | $110.21 | $114.75 | $107.09 | 441,200 | |
| $112.53 | +0.66 | +0.6% | $111.21 | $113.97 | $110.03 | 311,100 | |
| $111.87 | -1.48 | -1.3% | $113.21 | $114.75 | $111.35 | 359,000 | |
| $113.35 | +1.91 | +1.7% | $112.73 | $114.07 | $111.79 | 352,458 | |
| $111.44 | +1.44 | +1.3% | $112.29 | $113.60 | $109.89 | 400,563 | |
| $110.00 | +1.08 | +1.0% | $109.38 | $112.59 | $106.58 | 523,100 | |
| $108.92 | -6.81 | -5.9% | $114.51 | $114.61 | $108.73 | 568,600 | |
| $115.73 | +0.48 | +0.4% | $118.31 | $118.31 | $115.26 | 669,900 | |
| $115.25 | -0.19 | -0.2% | $115.25 | $117.16 | $114.33 | 447,000 | |
| $115.44 | -0.04 | 0.0% | $115.40 | $117.18 | $114.44 | 412,000 | |
| $115.48 | -0.54 | -0.5% | $115.22 | $117.33 | $113.66 | 334,900 | |
| $116.02 | -1.58 | -1.3% | $118.18 | $119.75 | $114.00 | 759,800 | |
| $117.60 | +4.755 | +4.2% | $111.58 | $118.50 | $111.42 | 574,300 | |
| $112.85 | -2.635 | -2.3% | $113.17 | $117.49 | $112.51 | 728,900 | |
| $115.48 | -0.15 | -0.1% | $115.57 | $116.89 | $113.67 | 738,600 | |
| $115.63 | +3.53 | +3.1% | $113.17 | $116.18 | $111.69 | 672,800 | |
| $112.10 | +1.39 | +1.3% | $110.03 | $112.30 | $108.49 | 944,300 | |
| $110.71 | +4.93 | +4.7% | $110.83 | $111.10 | $105.13 | 1,087,000 | |
| $105.78 | +3.00 | +2.9% | $100.68 | $108.65 | $97.57 | 1,643,700 | |
| $102.78 | +3.53 | +3.6% | $100.40 | $103.49 | $97.99 | 964,300 | |
| $99.25 | -6.49 | -6.1% | $105.74 | $106.87 | $98.44 | 471,700 | |
| $105.74 | -0.79 | -0.7% | $105.48 | $106.90 | $102.58 | 534,600 | |
| $106.53 | -1.51 | -1.4% | $107.62 | $108.40 | $105.86 | 502,200 | |
| $108.04 | +1.91 | +1.8% | $107.13 | $110.99 | $106.02 | 1,147,400 | |
| $106.13 | +4.03 | +3.9% | $104.64 | $109.53 | $102.75 | 727,700 | |
| $102.10 | -0.56 | -0.5% | $103.92 | $104.87 | $101.49 | 467,100 | |
| $102.66 | -1.31 | -1.3% | $101.64 | $103.32 | $101.04 | 470,600 | |
| $103.97 | -2.63 | -2.5% | $105.83 | $105.93 | $103.16 | 414,300 | |
| $106.60 | +2.00 | +1.9% | $104.18 | $107.18 | $104.18 | 520,700 | |
| $104.60 | -2.00 | -1.9% | $106.53 | $107.45 | $104.57 | 466,600 |
- Ticker
- Stuttgart:1RV
- Asset type
- Stock
- Exchange
- Stuttgart
- Currency
- EUR
What changed lately
Latest news release · Oct 13, 2026
Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE® (setmelanotide) in Japan for Patients with Acquired Hypothalamic Obesity
Latest earnings call · Aug 4, 2026
Rhythm Pharmaceuticals (NASDAQ:RYTM) Q2 2026 Earnings Call
Replay and transcript
Latest deck · September 2026
64th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE) 2026
Conference · 16 slides
Calls
Replays
Rhythm Pharmaceuticals (NASDAQ:RYTM) Q2 2026 Earnings Call
Tue, Aug 04, 2026 · 8:00 AM ET
Watch TranscriptRhythm Pharmaceuticals (NASDAQ:RYTM) Q1 2026 Earnings Call
Tue, May 05, 2026 · 8:00 AM ET
Watch TranscriptRhythm Pharmaceuticals (NASDAQ:RYTM) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE® (setmelanotide) in Japan for Patients with Acquired Hypothalamic Obesity
Oct 13, 2026
Closed $86.71 (+0.1%) on Oct 14, 2026
Rhythm Pharmaceuticals Announces Health Canada Approval of IMCIVREE® (setmelanotide) for Weight Management in Adult and Pediatric Patients 4 years of Age and Older with Acquired Hypothalamic Obesity
Sep 22, 2026
Closed $99.27 (+0.4%) on Sep 22, 2026
Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting
Sep 10, 2026
Closed $102.20 (+1.1%) on Sep 10, 2026
Rhythm Pharmaceuticals Announces MHLW Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity (HO) in Japan
Aug 24, 2026
Closed $111.44 (+1.3%) on Aug 24, 2026
Rhythm Pharmaceuticals Announces Appointment of Manher (AJ) Joshi as Chief Medical Officer
Aug 17, 2026
Closed $115.44 (0.0%) on Aug 17, 2026
Rhythm Pharmaceuticals Announces IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or Impairment
Aug 11, 2026
Closed $112.85 (-2.3%) on Aug 11, 2026
Rhythm Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update
Aug 4, 2026
Closed $105.78 (+2.9%) on Aug 4, 2026
Rhythm Pharmaceuticals Announces Preliminary Data from Phase 2 Trial that Showed RM-718 Demonstrated Positive Efficacy Signal in Acquired Hypothalamic Obesity
Aug 4, 2026
Closed $105.78 (+2.9%) on Aug 4, 2026
Rhythm Pharmaceuticals to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026
Jul 21, 2026
Closed $106.60 (+1.9%) on Jul 21, 2026
Decks
64th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE) 2026
Conference · 16 slides · September 2026
64th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE) 2026
Conference · 13 slides · September 2026
Investor Presentation (September 2026)
Investor deck · 66 slides · September 2026
Q2 2026 Earnings Presentation
Earnings · 31 slides · Aug 4, 2026
Rhythm Pharmaceuticals, Inc. on 6ix
- News releases
- 36 in the last 12 months · 220 in all · newest Oct 13, 2026 · oldest 2019
- Calls
- 21 calls with a replay · 21 with a transcript · latest Aug 4, 2026
- Decks
- 57 decks · latest September 2026
Where Rhythm Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:RYTM · Home listing | NASDAQ | United States | USD |
| LS Exchange:A2H5A0 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2H5A0 | Lang & Schwarz | Germany | EUR |
| gettex:1RV | gettex | Germany | EUR |
| Tradegate:1RV | Tradegate | Germany | EUR |
| BMV:RYTM | BMV | Mexico | MXN |
| BOATS:RYTM | BOATS | United States | USD |
| Frankfurt:1RV | Frankfurt | Germany | EUR |
| BIVA:RYTM | BIVA | Mexico | MXN |
| Dusseldorf:1RV | Dusseldorf | Germany | EUR |
| Munich:1RV | Munich | Germany | EUR |
| Stuttgart:1RV · This page | Stuttgart | Germany | EUR |
| Xetra:1RV | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about Rhythm Pharmaceuticals, Inc.